. This bioassay program was later transferred to the U.S. National Toxicology Program upon its establishment in 1978. In the bioassay program's combined 36 years of operation, approximately 500 chemicals have been studied for carcinogenicity and other chronic toxicities (5). These studies and the related range-finding and dose-setting studies are extremely expensive, they require large numbers of animals, and the study duration is long (6). Even though these studies are the gold standards, considering the approximately 70,000 to 600,000 chemicals in commerce (7-9), the number of chemicals for which we currently have adequate toxicology information for risk assessment is minuscule. At the present mode and rate of study of these chemicals, it is doubtful that our society will ever have a thorough toxicologic evaluation on the majority of the chemicals that are used now or may be used in the future. 
This paper is a presentation of the ongoing development of concepts and approaches toward predictive and alternative toxicology, particularly for chemical mixtures, from our laboratories, with collaboration from U.S. and European scientific colleagues. As a starting point, one asks why such a development is necessary. To (4) . This bioassay program was later transferred to the U.S. National Toxicology Program upon its establishment in 1978. In the bioassay program's combined 36 years of operation, approximately 500 chemicals have been studied for carcinogenicity and other chronic toxicities (5) . These studies and the related range-finding and dose-setting studies are extremely expensive, they require large numbers of animals, and the study duration is long (6) . Even though these studies are the gold standards, considering the approximately 70,000 to 600,000 chemicals in commerce (7) (8) (9) , the number of chemicals for which we currently have adequate toxicology information for risk assessment is minuscule. At the present mode and rate of study of these chemicals, it is doubtful that our society will ever have a thorough toxicologic evaluation on the majority of the chemicals that are used now or may be used in the future. Further consideration of the issue of health effects of This paper is based on a presentation at the Conference on Current Issues on Chemical Mixtures held 1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . The toxicologic end points of prediction, for instance, include an interaction threshold (18, 19) and acute lethality due to hepatic injuries (20) .
For more complex mixtures the integration of PBPK/PD, BBDR, QSAR modeling, and lumping analysis (a modeling tool developed in the petroleum industry) may allow the development of a predictive tool for the health effects (23) . In the 1960s the application of lumping analysis rendered it possible to predict gasoline production based on a few lumps (i.e., similar groups of chemicals based on carbon numbers or boiling points) rather than the thousands of component chemicals of the petroleum (24, 25 Because this is a review paper, many experimental details are not provided. Readers are referred to the papers cited for additional information. The following discussion will follow the chronological order of development of these approaches in our laboratories.
Experimental Approaches
This portion of the paper follows the evolution of our thinking in the last few years on how to develop predictive approaches for single chemicals and chemical mixtures. To focus our presentation we chose to limit the discussion to carcinogenesis only. Initially, we concentrated our effort on a medium-term (i.e., 8 weeks) in vivo experimental approach and its integration with PBPK/PD modeling. Although we made progress on this front and obtained interesting findings, it was soon obvious that even this shorter term, more efficient in vivo system was too resource intensive to be routinely used for chemical mixture work. Therefore, still more efficient systems must be developed. We investigated in vitro systems with our specific criteria (i.e., relatively simple, shortterm, and inexpensive; based on the best science; understanding mechanisms of toxicity; broad applicability; and predictive capability) in mind. We found that cell culture systems offer unique opportunities, particularly in mechanistic and time-course studies related to carcinogenesis. Thus, as a further development, in vitro mechanistic studies using cell culture systems and their Environmental Health Perspectives * Vol 106, Supplement 6 * December 1998 integration with pharmacodynamic modeling became a major emphasis in our laboratories. Our present thinking is that cell culture systems and in vivo animal studies may work in concert to bring about much-needed mechanistic and pharmacokinetic information for PBPK/PD modeling. When quantitative information on the selected molecular and cellular end points is available on chemicals with structural correlation, QSAR modeling may then be applied to assess their relationship with carcinogenic potentials. In doing so, the positive QSAR relationship between certain end points of a series of chemicals with their respective carcinogenic potentials may be used to develop a predictive approach for other untested chemicals with structural similarities.
The Medium-Term Liver Foci Bioassay
To simplify the detection of carcinogenicity of chemicals and chemical mixtures, Ito and colleagues developed the medium-term liver foci bioassay (30, 31) . The details of experimental protocol of this bioassay may be found in Ito et al. (30, 31) ; the bioassay is discussed briefly below.
The medium-term liver foci bioassay (30, 31) utilizes the placental form of glutathione S-transferase (GST-P) as a marker for rat hepatic preneoplastic and neoplastic lesions (32, 33) . The medium-term hepatocarcinogenesis bioassay of Ito et al. (30, 31) , an 8-week experiment, utilizes F344 rats that are given a single dose of diethylnitrosamine (DEN) to initiate carcinogenesis. After a 2-week period the rats are given repeated exposure to a test compound for a dosing period of 6 weeks. At the end of week 3, rats are subjected to partial hepatectomy to maximize opportunities of promotion via a high rate of cell proliferation. All rats are sacrificed at the end of week 8 for evaluation of development of preneoplastic hepatocellular nodules by staining for expression of GST-P (30, 31) . Extensive testing has demonstrated that the induction of GST-P-positive foci in the medium-term bioassay for liver carcinogens correlates well with the incidence of hepatocellular carcinomas in parallel long-term assays (30, 31 Figure 2 . Because cell-cycle kinetics was incorporated into this model, our initial effort was devoted to a biologically based mathematical model of the effects of partial hepatectomy on cell cycle kinetics (38) and a comparison of quantitative immunohistochemical markers for cell-cycle specific changes in F344 rats (39) . However, it was soon apparent that there were two pitfalls. First, whereas the proliferating cell nuclear antigen staining appeared to work well for the liver cells undergoing rapid proliferation such as after two-thirds partial hepatectomy (39), quantitative morphometric analysis would be prohibitively resource-intensive for liver at resting state, which has a low rate of cell turnover. Second, although a biologically motivated model depicting cell-cycle kinetics a) (30, 31 was constructed and computer simulations were consistent with available literature data (38) , the data requirements for applying such a model to the specific chemicals and bioassay systems that we were studying were beyond the reach of our available resources and personnel. Thus, we were overly ambitious in our initial modeling attempt.
In the next stage we simplified the model greatly. As shown in Figure 3, c-fosalteratons is summarized in Figure 6 . There are many phenotypic and genotypic changes accompanying the transformation of human keratinocytes; some are early events and others are late events. To cover these changes, commercially available primary human keratinocytes may be used to study the early events (43 Figure 7 . We believe that because cancer is a cellular process, the carcinogenic potential of chemicals can be identified through the studies of selected key molecular/cellular markers of the cancer processes; also, QSAR and pharmacodynamic modeling of these key biomarkers for cellular process can be effectively utilized to develop a predictive tool for evaluating carcinogenic potential within certain classes of chemicals.
We listed multiple chemicals for chemical mixtures, but this general approach ( Figure 7 ) is applicable for s as well. The short-term alt may be represented by the ' formation assay and the n course medium-term li ( Figure 1) Our plan is to build and verify QSAR SHE cell trans-models based on our ongoing studies of nodified time-molecular and cellular biomarkers of prever foci assay neoplastic foci formation from exposures :s are available. to hexa-, penta-, 1,2,4,5-tetra-, and 1,4-iomarkers from dichlorobenzenes; to use these verified ading toward QSAR models to predict each of the toxi-,rowth control, cologic responses and PBPK modeling s, loss of DNA parameters studied to date for the remainf targeted by a ing eight chlorobenzene isomers (1,2,3,4-npounds. From tetra-, 1,2,3,5-tetra-, 1,2,3,-tri-, 1,2,4,-tri-, rate constants 1,3,5-tri-, 1,2-di-, 1,3-di-, and monoand mutation chlorobenzenes); and to verify the QSAR Drtal cells, rates model predictions by conducting molecuctors, and/or lar biology/biochemical experiments and nd tumor-sup-PBPK/PD modeling studies on selected erated for con-chlorobenzene isomers using in vitro and s). Quantitative in vivo methods. To achieve that we will lar/cellular bio-proceed as follows: ess may be used
The array of toxicologic data on the ass of chemicals first four selected chlorobenzenes will be ral similarities. studied using pattern recognition methods PBPK model-(50,51) to determine which data correlate g (i.e., PBPD with the carcinogenic nature of the com-5 us with a tool pounds. The methods that will be used are toxicology and principal component analysis, linear discriminant analysis, cluster analysis, and soft independent modeling of class analogy and QSAR (50, 51 (52) (53) (54) . The correlation developed will be similar to the following description, with the understanding that actual relationships will be calculated using partial least square (PLS) regression analysis ( The role of QSAR modeling in the overall scheme is to provide interpolations and extrapolations for estimated values for TRs and PKs for those chemicals that are not studied experimentally in a class of chemicals (such as chlorobenzenes) or chemical mixtures (such as hydrocarbons, metals, etc.). These gaps may be filled using QSAR based on structural differences and the related physicochemical changes. In doing so we may carry out PBPK/PD or BBDR modeling on these chemicals or chemical mixtures on an a priori basis.
Discussion in this paper consists of past and ongoing studies as well as theoretical deliberations. Much of the development is still at an embryonic stage. We invite criticisms and suggestions for further modification and refinement of our approaches. Through this type of process we will be able to work toward the goal of establishing a scientifically credible predictive and alternative toxicology.
